Comparative analysis of clinical pharmacists’ perspectives on barriers and facilitators in implementing smart insulin pens versus traditional insulin pens in India
| dc.contributor.author | Cherian Varghese, Ruben | |
| dc.date.accessioned | 2024-10-29T15:27:06Z | |
| dc.date.available | 2024-10-29T15:27:06Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Diabetes is a chronic metabolic condition indicated by high blood glucose levels, if left untreated can lead to severe complications that affect the overall health of the patient. About 422 million individuals are globally affected with diabetes, particularly in low and middleincome countries like India. The management of diabetes is a major challenge faced in many countries even though there are advanced technologies that are available for the management of diabetes. The management of diabetes mainly depends on the adherence of the patient to the treatment. The development of advanced technologies plays a crucial role in the management of diabetes. The study was focused on exploring the various perspectives of clinical pharmacists on the barriers and facilitators for the implementation of smart insulin pens when compared to traditional insulin pens where the management of diabetes is a growing challenge in India. The study employed a qualitative approach where interviews were conducted with 8 clinical pharmacists. The study explored the barriers and facilitators for the implementation of smart insulin pens in India, assessed the cost-effectiveness, and explored the perceptions of the clinical pharmacists on the traditional insulin pens and smart insulin pens. The results obtained from the study identified the barriers and facilitators for the implementation of smart insulin pens. The technical challenges include connectivity issues and data security, and the behavioral challenges include patient resistance and the learning curve as challenges. The facilitators for the implementation factors include advanced features such as dose reminders, dose tracking, and data sharing capability which is beneficial for both the patients and the healthcare professionals. The study also found that smart insulin has a high initial cost but it is found to be cost-effective in the long run because of its ability to reduce the complications associated with diabetes. From the data analyzed it is clear that smart insulin pens have several benefits when compared to traditional insulin pens and they can potentially contribute to the management of diabetes. The smart insulin pen has the potential to improve health outcomes and also improve patient management due to its facilitating features. The study also identified crucial factors for the implementation of the smart insulin pen such as thorough training, continuous education, and support from the technology providers that can potentially enhance the adoption of the smart insulin pens | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14136/196 | |
| dc.title | Comparative analysis of clinical pharmacists’ perspectives on barriers and facilitators in implementing smart insulin pens versus traditional insulin pens in India | |
| dc.type | Thesis |